We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Oxford Gene Technology and Nimblegen Systems Enter Into Licensing and Supply Agreements
News

Oxford Gene Technology and Nimblegen Systems Enter Into Licensing and Supply Agreements

Oxford Gene Technology and Nimblegen Systems Enter Into Licensing and Supply Agreements
News

Oxford Gene Technology and Nimblegen Systems Enter Into Licensing and Supply Agreements

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Oxford Gene Technology and Nimblegen Systems Enter Into Licensing and Supply Agreements"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Oxford Gene Technology (OGT) and NimbleGen Systems, Inc. are pleased to announce that NimbleGen has obtained a license to OGT's Southern array patents, the fundamental patents covering the manufacture and commercialization of oligonucleotide arrays.

At the same time the Companies entered into a Supply Agreement under which OGT will be able to obtain DNA microarrays from NimbleGen for use in OGT's service business, and NimbleGen will be able to make and sell OGT-designed arrays.  Terms of the agreements were not disclosed.

“Successful discussions with NimbleGen have concluded with the granting of this license thus enabling NimbleGen to deliver their microarray products and services worldwide and adding to OGT’s growing portfolio of North American licensees,” stated Sue Sutton, Vice President Licensing North America at OGT.

“We are also looking forward to being able to offer NimbleGen’s high-density microarrays within our microarray service business.”

Dr. Stan Rose, President and CEO of NimbleGen, said, "NimbleGen has long been an admirer of the work of Professor Ed Southern, and we’re delighted to have expanded our relationship with these new agreements. They provide NimbleGen with access to important intellectual property rights relevant to our core business, as well as an exciting new commercial relationship that should benefit both companies."

Advertisement